ClinicalTrials.gov
public full text
Public Domain
Evaluation of the Performance and Safety of the MD60000 Device in the Treatment of Skin Imperfections Due to Aging.
Here is the English translation of the summary: The Clinical Investigation Plan with code CIP-01-25 outlines a single-center, uncontrolled, single-arm clinical study sponsored by Promoitalia Group S.p.A. and conducted at the Casa di Cura Santa Maria La Bruna in Torre del Greco under the responsibility of Principal Investigator Giuseppe Ferraro, with Teia Research S.r.l. acting as the CRO. The primary objective of the study is to evaluate the aesthetic performance and safety of the MD60000 medical device, an intradermal, biodegradable, sterile, and isotonic gel based on 3.3% linear hyaluronic acid integrated with PLA, intended for the correction of skin imperfections caused by physiological skin aging, such as facial wrinkles. The investigation is conducted pursuant to Article 61 of the European Medical Device Regulation 2017/745 (MDR) in order to collect clinical data for regulatory conformity assessment, adhering to ISO 14155 standards and the Declaration of Helsinki. The study design involves enrolling forty-three adult patients aged between eighteen and sixty-five years with facial skin defects characterized by a baseline score of one or higher on the Lemperle Wrinkle Severity Scale. Patients with skin diseases, active infections, or recent aesthetic treatments in the same anatomical area are excluded, as well as pregnant or breastfeeding women, individuals with a history of allergic reactions to the components, autoimmune diseases, coagulation disorders, or a predisposition to hypertrophic scars or keloids. Participation for each subject ranges between forty-five and sixty-five days, while the overall estimated duration of the entire clinical investigation is approximately six months. The procedural pathway comprises four main visits. During the first screening and baseline visit, eligibility criteria are verified, informed consent and medical history are collected, and baseline photographic evaluations and wrinkle severity assessments are performed. If condi
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Evaluation of Performance and Safety of INNEA and INNEA AQUA for the Treatment of Cheek and décolletage Wrinkles#914253
- The Value of Home Chlorhexidine Pre-Surgical Wash Before Spine Surgery#1096541
- Evaluation of the Re-volumizing Performance of Aliaxin (New Trademark)#1194936
- Evaluate the Safety and Effectiveness of Sodium Hyaluronate When Used for the Correction of Nasolabial Folds#880099
- Post Marketing Clinical Follow up Study to Evaluate the Performance and Safety of HYALEXO#969702
Record · ID 1365449
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive